Circulating lncRNA H19 may be a useful marker of response to neoadjuvant chemotherapy in breast cancer
Tarih
2020Yazar
Saip, Pinar
Ozgur, Emre
Sen, Fatma
Gezer, Ugur
Ferhatoglu, Ferhat
Üst veri
Tüm öğe kaydını gösterÖzet
BACKGROUND: Novel biomarkers are needed to predict the effectiveness of the treatment of presurgical neoadjuvant chemotherapy (NAC) in breast cancer (BC).
Koleksiyonlar
- Makale [92796]